Related Experiment Videos
Macrophage colony-stimulating factor: biological effects and potential applications for cancer therapy
D F Bajorin1, N K Cheung, A N Houghton
1Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
Seminars in Hematology
|April 1, 1991
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Adjuvant nivolumab versus placebo for high-risk muscle-invasive urothelial carcinoma: 5-year efficacy and ctDNA results from CheckMate 274.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Oncologic outcomes of retroperitoneal lymph node dissection following first-line chemotherapy for metastatic non-seminomatous germ-cell tumors.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology·2019
Trauma team activation criteria and outcomes of geriatric trauma: 10 year single centre cohort study.
The American journal of emergency medicine·2018
Germline predisposition in myeloproliferative neoplasms.
Seminars in hematology·2026
Alloimmunization in sickle cell disease: Addressing an ongoing clinical challenge.
Seminars in hematology·2026
Pain in SCD-Many mechanisms and mysteries.
Seminars in hematology·2026